Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2009 May;75(5) > Minerva Anestesiologica 2009 May;75(5):333-37

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623


eTOC

 

REVIEW ARTICLES  FREEfree


Minerva Anestesiologica 2009 May;75(5):333-37

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Dopamine versus norepinephrine: is one better?

Vincent J. L. 1, Biston P. 2, Devriendt J. 3, Brasseur A. 1, De Backer D. 1

1 Department of Intensive Care, Erasme Hospital; 2 CHU Charleroi, Brussels, Belgium; 3 Brugmann Hospital, Université libre de Bruxelles, Brussels, Belgium


FULL TEXT  


Dopamine and norepinephrine are widely used as first line agents to correct hypotension in patients with acute circulatory failure. There has been considerable debate in recent years as to whether one is better than the other. Both drugs can increase blood pressure in shock states, although norepinephrine is more powerful. Dopamine can increase cardiac output more than norepinephrine, and in addition to the increase in global blood flow, has the potential advantage of increasing renal and hepatosplanchnic blood flow. However, dopamine has potentially detrimental effects on the release of pituitary hormones and especially prolactin, although the clinical relevance of these effects is unclear. Observational studies have provided conflicting results regarding the effects of these two drugs on outcomes, and results from a recently completed randomized controlled trial are eagerly waited.

top of page

Publication History

Cite this article as

Corresponding author e-mail